Targeting Large B-Cell Lymphoma: Advances in Treatment

TARGET AUDIENCE:
This activity is designed to meet the educational needs of hematology/oncology physicians, nurse practitioners, nurses, PAs, pharmacists, and other healthcare professionals who care for patients with DLBCL.
PROGRAM OVERVIEW:
The archived version of an interactive nationwide webinar focused on advances in the management of patients with diffuse large B-cell lymphoma (DLBCL).
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be better able to:
- Review current treatment options and evidence-based guidelines for the incorporation of targeted therapies into the management of DLBCL
- Apply strategies to mitigate and manage common adverse events associated with targeted therapies used to treat patients with DLBCL
- Discuss unmet needs and potential future advances in DLBCL treatment